Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Barclays cuts Prudential price target to 1,250 (1,380) pence - 'overweight' Barclays reinitiates Barratt Developments with 'overweight' - price target 641 pence Barclays raises HGCapital Trust to ...

Recursion Pharmaceuticals Inc RXRX shares are trading lower. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...

The workers of Square Pharmaceutical have blocked the Dhaka-Tangail highway with 21-point demands including salary increase, job stabilization, and two-day weekend. The workers of Square ...

Hikma Pharmaceuticals PLC HIK shares inched down 0.50% to £19.83 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.04% ...

The Indian pharmaceutical industry is expected to witness significant growth by 2030, driven by new regulatory measures and technological advancements, according to a report from Pharmarack ...